N01191 102 — Stanford, California

N01191 102 is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

N01191 102 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy, Partial.

Sponsors: UCB S.A. - Pharma Sector.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01191 102?

N01191 102 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01191 102 conducted?

N01191 102 has 1 clinical trials on record. Their work covers Epilepsy, Partial.

Is N01191 102 accredited by Crixeo Health?

N01191 102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01191 102?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.